Michael S Yee

Learn More
BACKGROUND There is recent evidence suggesting that rosiglitazone increases death from cardiovascular causes. We investigated the direct effect of this drug on atheroma using 3D carotid cardiovascular magnetic resonance. RESULTS A randomized, placebo-controlled, double-blind study was performed to evaluate the effect of rosiglitazone treatment on carotid(More)
  • 1